Digitally Driven Pharma

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I bring over two decades of experience in the pharmaceutical industry, having held leadership roles across multinational and regional companies. My career spans commercial leadership, strategic operations, and country management. I’ve led P&L responsibilities, spearheaded market access initiatives, and driven successful product launches across diverse therapeutic areas, including chronic diseases, specialty care, and injectables. Currently, I lead operations at Labatec Pharma in the GCC, where I oversee strategic growth across three key lines: Oral, Injectables, and New Launches. My expertise lies in navigating complex regulatory landscapes, building agile commercial teams, and shaping effective go-to-market strategies in competitive and rapidly evolving markets.

Q2. How is digital transformation (e.g., e-health, telemedicine, AI in R&D) impacting the commercial and operational side of pharma in your country?

Digital transformation is steadily reshaping the pharmaceutical landscape in the UAE. On the commercial front, digital health tools have improved engagement models with HCPs and patients, particularly via telemedicine platforms and e-detailing solutions, which we applied before. We’re seeing increased reliance on data analytics for customer segmentation. Operationally, AI-driven forecasting, supply chain digitization, and the…